MannKind Corp. (MNKD) Scheduled to Post Quarterly Earnings on Monday
MannKind Corp. (NASDAQ:MNKD) is scheduled to issue its quarterly earnings data on Monday, November 4th. Individual that are interested in participating in the company’s earnings conference call can do so using this link.
MannKind Corp. (NASDAQ:MNKD) last released its earnings data on Friday, August 9th. The company reported ($0.16) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.14) by $0.02. On average, analysts expect MannKind Corp. to post $-0.57 EPS for the current fiscal year and $-0.20 EPS for the next fiscal year.
Shares of MannKind Corp. (NASDAQ:MNKD) opened at 4.905 on Friday. MannKind Corp. has a 1-year low of $1.88 and a 1-year high of $8.70. The stock has a 50-day moving average of $5.47 and a 200-day moving average of $6.0. The company’s market cap is $1.432 billion.
A number of analysts have recently weighed in on MNKD shares. Analysts at Zacks reiterated a “neutral” rating on shares of MannKind Corp. in a research note to investors on Tuesday, October 15th. They now have a $5.50 price target on the stock. On a related note, analysts at Bank of America Corp. downgraded shares of MannKind Corp. from a “neutral” rating to an “underperform” rating in a research note to investors on Friday, September 6th. They now have a $5.00 price target on the stock, down previously from $8.00. Finally, analysts at MLV Capital raised their price target on shares of MannKind Corp. from $8.00 to $11.00 in a research note to investors on Thursday, August 15th. They now have a “buy” rating on the stock. One investment analyst has rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $7.17.
MannKind Corporation (NASDAQ:MNKD) is a development-stage biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.